Browsing by Subject "Genome wide association study"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets
    (Wiley, 2023) Ramos, Jairo; Caywood, Laura J.; Prough, Michael B.; Clouse, Jason E.; Herington, Sharlene D.; Slifer, Susan H.; Fuzzell, M. Denise; Fuzzell, Sarada L.; Hochstetler, Sherri D.; Miskimen, Kristy L.; Main, Leighanne R.; Osterman, Michael D.; Zaman, Andrew F.; Whitehead, Patrice L.; Adams, Larry D.; Laux, Renee A.; Song, Yeunjoo E.; Foroud, Tatiana M.; Mayeux, Richard P.; St. George-Hyslop, Peter; Ogrocki, Paula K.; Lerner, Alan J.; Vance, Jeffery M.; Cuccaro, Michael L.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Scott, William K.; Medical and Molecular Genetics, School of Medicine
    Introduction: Studies of cognitive impairment (CI) in Amish communities have identified sibships containing CI and cognitively unimpaired (CU) individuals. We hypothesize that CU individuals may carry protective alleles delaying age at onset (AAO) of CI. Methods: A total of 1522 individuals screened for CI were genotyped. The outcome studied was AAO for CI individuals or age at last normal exam for CU individuals. Cox mixed-effects models examined association between age and single nucleotide variants (SNVs). Results: Three SNVs were significantly associated (P < 5 × 10-8 ) with AAO on chromosomes 6 (rs14538074; hazard ratio [HR] = 3.35), 9 (rs534551495; HR = 2.82), and 17 (rs146729640; HR = 6.38). The chromosome 17 association was replicated in the independent National Institute on Aging Genetics Initiative for Late-Onset Alzheimer's Disease dataset. Discussion: The replicated genome-wide significant association with AAO on chromosome 17 is located in the SHISA6 gene, which is involved in post-synaptic transmission in the hippocampus and is a biologically plausible candidate gene for Alzheimer's disease.
  • Thumbnail Image
    Item
    Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder
    (Cambridge University Press, 2023) Johnson, Emma C.; Kapoor, Manav; Hatoum, Alexander S.; Zhou, Hang; Polimanti, Renato; Wendt, Frank R.; Walters, Raymond K.; Lai, Dongbing; Kember, Rachel L.; Hartz, Sarah; Meyers, Jacquelyn L.; Peterson, Roseann E.; Ripke, Stephan; Bigdeli, Tim B.; Fanous, Ayman H.; Pato, Carlos N.; Pato, Michele T.; Goate, Alison M.; Kranzler, Henry R.; O’Donovan, Michael C.; Walters, James T. R.; Gelernter, Joel; Edenberg, Howard J.; Agrawal, Arpana; Medical and Molecular Genetics, School of Medicine
    Background: Alcohol use disorder (AUD) and schizophrenia (SCZ) frequently co-occur, and large-scale genome-wide association studies (GWAS) have identified significant genetic correlations between these disorders. Methods: We used the largest published GWAS for AUD (total cases = 77 822) and SCZ (total cases = 46 827) to identify genetic variants that influence both disorders (with either the same or opposite direction of effect) and those that are disorder specific. Results: We identified 55 independent genome-wide significant single nucleotide polymorphisms with the same direction of effect on AUD and SCZ, 8 with robust effects in opposite directions, and 98 with disorder-specific effects. We also found evidence for 12 genes whose pleiotropic associations with AUD and SCZ are consistent with mediation via gene expression in the prefrontal cortex. The genetic covariance between AUD and SCZ was concentrated in genomic regions functional in brain tissues (p = 0.001). Conclusions: Our findings provide further evidence that SCZ shares meaningful genetic overlap with AUD.